sulfasalazine has been researched along with Anterior Horn Cell Disease in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Excerpt | Relevance | Reference |
---|---|---|
"We observed previously established medical associations for MND and an inverse dose-response association between lovastatin and MND, with 28% reduced risk at 40 mg/day." | 1.91 | Protective Effects of Lovastatin in a Population-Based ALS Study and Mouse Model. ( Kreple, CJ; Miller, TM; Racette, BA; Schoch, KM; Searles Nielsen, S; Shabsovich, M; Shen, T; Song, Y, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kreple, CJ | 1 |
Searles Nielsen, S | 1 |
Schoch, KM | 1 |
Shen, T | 1 |
Shabsovich, M | 1 |
Song, Y | 1 |
Racette, BA | 1 |
Miller, TM | 1 |
1 other study available for sulfasalazine and Anterior Horn Cell Disease
Article | Year |
---|---|
Protective Effects of Lovastatin in a Population-Based ALS Study and Mouse Model.
Topics: Aged; Amyotrophic Lateral Sclerosis; Animals; Case-Control Studies; Disease Models, Animal; Humans; | 2023 |